Purpose of Review In this review, the contribution of NMR to the metabolomics field will be discussed-particularly as it relates to cancer and drug metabolism research. An overview of the typical NMR metabolomic experiment will be presented while emphasizing important caveats ranging from experimental design to data interpretation. Recent Findings Despite some of the drawbacks of NMR, including reduced sensitivity compared to mass spectrometry-based approaches, NMR-based metabolomic approaches have provided considerable insight into drug and cancer metabolism. Advances in flux analysis based on the strategic use of isotopes have generated unique perspectives of cancer from the cellular and tissue levels. Summary Combined with other "omics" tools, including genomics, proteomics, and transcriptomics, metabolomic analysis completes the holistic view of metabolism. Many of these NMR-based approaches are likely to find their way into the clinic and become a common diagnostic tool.
Introduction
Metabolomics is an informative analytical platform providing both quantitative and qualitative measurements of metabolites. Metabolomics has established itself an indispensable tool for understanding the systemic responses to developmental and/or physiological change [1, 2] as well as exposure to exogenous stimuli, such as diet and xenobiotics [3, 4] . Metabolomics is located downstream of genomics, transcriptomics, and proteomics and enriches the system-level view by directly assaying metabolites, their concentration, and even flux through metabolic pathways [5] . The metabolomics field continues to develop rapidly, and its exponential increase as a tool in scientific publication demonstrates its extensive application in many fields [6] .
Currently, the mainstream metabolomic platforms include chromatography (e.g., liquid, gas, and capillary electrophoresis) coupled with mass spectrometry (MS), direct infusion MS, and nuclear magnetic resonance spectroscopy (NMR). MS-based metabolomic approaches in drug metabolism, biomarkers, and toxicology have been extensively reviewed elsewhere [7, 8] . Each method has its own advantages and limitations. In reality, no perfect analytical technique can completely profile a metabolome in its entirety. The choice of suitable analytical methods therefore depends on the study objectives and the sample type to be analyzed. Employing a multiplatform approach is the best way to conduct a metabolomic investigation of complex biological samples [9] . In this review, the NMR-based metabolomic approach will be highlighted and its application in cancer and drug metabolism research.
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As a primary tool for the structural, qualitative, and quantitative analysis of biomacromolecules such as proteins and nucleic acids [10, 11] , NMR-based approaches have been instrumental for the identification of metabolites (knowns and unknowns of both endogenous and xenobiotic chemicals) in biofluids (e.g., plasma, serum, and urine), cell and tissue extracts, and whole organisms. In addition to metabolite structural determination, NMR offers excellent and reproducible quantitative analysis and the potential for high throughput with flow injection technology [12, 13] . While NMR suffers from relatively poor sensitivity compared to MS approaches, stable isotope labeling approaches (e.g., 31 P, 13 C, 15 N, and 2 H) not only have provided structural information of unknown metabolites but also have been helpful in elucidating the flow of metabolic pathways and their connections. Furthermore, stable isotope approaches make it possible to understand and measure flux through specific pathways, which provides the metabolic rate or metabolic path as opposed to the starting and final concentration of metabolites [14, 15] . With this information, NMR-based metabolomics has been successfully used in toxicology [4, 16, 17] , pathophysiology [18, 19] , understanding gene function [20] , and for rapid diagnosis, therapeutics, and prognosis of metabolic disease using cell, animal models, and human samples [21, 22] (Fig. 1a) .
Of note, NMR-based metabolomics has also been used to identify biomarkers for cancer, including hepatocellular carcinoma (HCC) [23, 24] , colon cancer [25] , ovarian cancer [26] , and breast cancer [27] . These approaches are essential in order to shorten the time to diagnosis-especially in cancers for which early detection and screening are difficult but would significantly impact therapeutic treatment decisions as well as prognosis. For example, Yang et al. identified metabolites in low-grade and highgrade human HCC and the adjacent normal tissue using a high-resolution, magic-angle spinning (HRMAS) 1 H NMR metabolomic approach [28] . Odunsi et al. used 1 H NMR to identify a metabolic profile or chemical fingerprint of ovarian cancer in serum by comparing results from those obtained with healthy postmenopausal women [29] . Metabolomics has also been applied in evaluating cancer radiotherapy. For example, using an isotopomer approach, Lane et al. identified a metabolite signature of apoptosis in cervical carcinoma cells following radiotherapy [15] . All of these studies demonstrate that information generated from NMR-based metabolomic studies can be useful in biomarker studies and for understanding the efficacy of treatment options. The aims of this next section are to first describe the NMRbased metabolomic approach and to then consider which NMR platform-taking into account all advantages and disadvantages-should be considered for analysis of biofluids, tissues, and tissue extracts. Figure 1b shows the basic workflow of an NMR-based metabolomic approach. Considering the unique characteristics (e.g., editing techniques) and shortcomings (e.g., low signalto-noise and low sensitivity) of NMR, the workflow begins with experimental design, including ensuring that the study is properly powered (i.e., having appropriate sample numbers to yield informative and statistically significant results) and that confounding variables have been considered. The workflow proceeds through the biological and subsequent analytical experiments, such as sample preparation, NMR data acquisition, and signal preprocessing, on to data analysis, and then to interpretation of the results. To produce robust and valid results, it is essential to choose the correct option for specific experiments, since multiple options exist for each step in the workflow (e.g., different methods of metabolite extraction and statistical data analysis). Although multiple factors influence metabolomic experiments, some can be controlled under laboratory conditions. Perhaps the most easily controlled metabolomic application is in NMR-based toxicologic research. For example, within the framework of the well-known Consortium for Metabonomics Toxicology [30, 31] , which was formed by Imperial College London in collaboration with several pharmaceutical companies, an NMR-based metabolomic approach was used to develop a better understanding of organ toxicity using approximately 150 known toxicants and rodent models. Multiple factors, such as time points, dosage, and exposure pathways of toxicants, were extensively considered and controlled.
NMR-Based Metabolomic Approach
The comparisons between two or more groups, excluding potential interfering factors, are essential for extracting useful information. As for the studies related to diseases in humans, which can be difficult to adequately control due to differences in diet, lifestyle, and environment, NMR-based metabolomics has also been used to investigate the development, progression, diagnosis, and prognosis of diseases such as obesity [32] and diabetes [33] , using cohorts in which groups are established as exposed (cases) versus nonexposed (controls). Within these cases, many factors, including age, gender, and lifestyle, may contribute to an observed condition, which should be considered to ensure that the two groups are as well matched as possible. In short, regardless of which NMR-based metabolomic approach is applied to highly controlled research or in clinical studies, it is critical to begin with detailed and extensively considered experimental strategy and design.
Sample requirements for metabolomics depend on the experimental goals and methods. Normally, the closer the samples' physiological status to the animal, human, or plant, the more representative the snapshot of the metabolome will be of the actual condition. For NMR-based methods, biofluids (e.g., urine, whole blood, serum, or plasma) and tissues (e.g., liver, brain, or kidney) are generally examined directly, without extensive sample preparation, so that in vivo and in situ information is easily obtained. As little as 2 μL of biofluids and 10 mg of tissues are required to obtain metabolite information with particular techniques, such as flow injection and NMR cryo probes [34] [35] [36] . For example, it is possible to analyze intact tissues (e.g., liver, kidney, and heart), plants, microbiota, or cells directly by employing HRMAS NMR to detect a chemical fingerprint [37, 38] . This method has already been extensively applied in tissue metabolomic studies [28] . Unfortunately, some metabolites can be highly influenced by pH (e.g., citrate and histidine). The addition of phosphate buffer (NaH 2 PO 4 / K 2 HPO 4 ) can be used to adjust the pH (~7.4) of the solution to minimize this effect. The property of pH sensitivity is usually employed to investigate the microenvironment of the cellparticularly that of the cancer cell [39, 40] . In addition, different ionic concentrations of salt in solution (especially calcium and magnesium ions in urine) can cause the chemical shift to drift, which can be optimized by adding the appropriate potassium or sodium fluoride solution to decrease the concentration of Ca 2+ and Mg 2+ with ion exchange reactions [41, 42] . In addition, the methods of metabolite extraction for feces and tissues in NMRbased metabolomics can be further optimized by selecting the appropriate solvents (e.g., methanol and acetonitrile) or extraction procedure, although protocols vary across research groups [43, 44] . Samples should be snap-frozen in liquid nitrogen and stored at −80°C until analysis.
After preparing samples for NMR analysis, NMR signals (e.g., those from small molecules and lipid proteins) can be obtained without separation (e.g., chromatography) of metabolites by using different NMR methods. For most biological samples, including urine and plasma/serum, aqueous extracts of feces, cells, and tissues, the typical NOESYPR1D pulse sequence (recycle delay-90°-t 1 -90°-t m -90°-acquisition) ( Fig. 2a) provides solvent suppression while maintaining a flat baseline and is usually used to record a comprehensive view of the sample metabolites (Fig. 2d) . However, for plasma/ serum and intact tissues containing not only a small molecule but also lipids and proteins, a water-presaturated Carr-PurcellMeiboom-Gill (CPMG) pulse sequence (recycle delay-90°-(τ-180°-τ)n-acquisition) ( Fig. 2b ) and a normal T 2 (spin-spin relaxation time)-edited method due to the different T 2 between small molecules and macromolecules are used to attenuate NMR signals from macromolecules by adjusting the spinspin relaxation delays (2nτ~100 ms) (Fig. 2e) . In order to analyze the macromolecules in plasma or serum using NMR, diffusion-weighted ( Fig. 2c ) spectra can be acquired to uniquely distinguish NMR signals of molecules according to their diffusion coefficient (Fig. 2f) . Furthermore, to improve the detection of lipids and other biomacromolecules, diffusion-ordered spectroscopy (DOSY) is commonly used to selectively remove fast-diffusing (low molecular weight) metabolites. This diffusion method is also helpful in rapidly identifying some metabolites, such as lipids and oligosaccharides, which are difficult to identify due to their significant overlap with other 1 H NMR signals [45, 46] . Although many advanced NMR pulse sequences designed for structural biology research can be used to analyze the metabolome of complex systems, such as biofluids and tissues, 1 H NMR spectroscopy suffers from poor resolution of metabolites with similar resonances (e.g., those in the same region of the NMR spectrum), resulting again in significant overlap of signals-for instance, the thousands of 1 H NMR signals from all metabolites located in the spectral region of less than 10 ppm. However, 2D NMR techniques or nuclei with more dispersion, such as 13 C and 31 P, can be used to help uniquely identify metabolites.
All 1 H NMR spectra are corrected manually for phase and baseline distortions, and spectral regions (e.g., δ 0.5-9.5 for urine) are integrated into buckets with equal width (e.g., 2.4 Hz for 600 MHz NMR machine). Regions distorted by imperfect water saturation and its high variability should be discarded with the regions containing signals of urea or exogenous compounds (e.g., contaminants including those generated during sample extraction and preparation). Each bucketed region is then normalized to compensate for the overall concentration differences prior to statistical data analysis. To facilitate NMR signal assignments, a series of 2D NMR spectra are normally employed for selected samples-including C heteronuclear multiple bond correlation spectra (HMBC)-and further confirmed with previous publications [47, 48] and a variety of online databases, such as the Human Metabolome Database (HMDB) [49, 50] , the Madison Metabolomics Consortium Database [51] , and the BioMagResBank (BMRB) [52] . As for the remaining metabolites that are difficult to identify due to low concentration, a combination of other hyphenated techniques can be used, such as liquid chromatography (LC)-NMR and/or LC-NMR-MS and solid-phase extraction, which have been extensively employed in natural product studies and plant secondary metabolite identification.
To analyze NMR data, multivariate data analysis is performed to uncover latent variables that may be informative about the metabolic differences between groups. Principal component analysis (PCA), an unsupervised multivariate data analytical method, is initially employed on mean-centered NMR data to generate an overview and to identify any abnormalities or outliers within the data set. Subsequently, supervised multivariate data analytical tools, projection to latent structure discriminant analysis (PLS-DA), and orthogonal projection to latent structure discriminant analysis (OPLS-DA) are applied to the analysis of 1 H NMR spectral data scaled to unit variance. PLS-DA and OPLS-DA models are then validated using a sevenfold cross-validation method [53] and further evaluated with a permutation test (200 permutations) and CV-ANOVA approach (p < 0.05) [54, 55] . The scores and loading plots are used to extract significantly altered metabolites with pairwise comparison. Data visualization is preferred in metabolomic experiments due to the high dimensionality of the data collected. One particularly useful visualization method developed by the Nicholson research group is the color-coded correlation coefficient loading plot calculated from back-transformation of the loadings [4] , in which the color-coded correlation coefficient indicates the significance of the metabolite contribution to the class separation, with a "hot" color (e.g., red) being more significant than a "cold" color (e.g., blue). A cutoff value is chosen according to the sample number for correlation coefficient as significant based on the discrimination significance (p < 0.05). Biological meaningfulness of data is the ultimate aim for metabolomic studies. Most commonly, the significantly changed metabolites obtained from multivariate statistical analysis of NMR data are mapped to a metabolic pathway according to the KEGG database [56] . However, only those relatively high-concentration metabolites are observed by the NMR technique due to its insensitivity. Many of these metabolites, such as glucose, glutamine, and adenosine triphosphate (ATP), are found in several different metabolic pathways, and they can be perturbed by a variety of diseases or other pathophysiological states. For example, the significance of glucose changes usually involved in glycolysis or gluconeogenesis is extremely different between liver or kidney toxicity and diabetes research [57] . Therefore, the interpretation of such data should be specific to the study objective and its interpretation carefully considered-especially as it relates to the specificity of the metabolite to the observed disease. In addition, isotope labeling ( 13 C or 14 N) is a very powerful tool for tracking and monitoring the metabolites (usually referred to as biomarkers) to identify the specific metabolic pathway that has changed significantly-a technique that has been extensively applied in metabolic flux research [58] .
The Advantages and Disadvantages of NMR Spectroscopy
NMR is an invaluable tool for chemists, structural biologists, and metabolism investigators and as such has been extensively employed in metabolic profiling research [59] . The NMRbased method is user-independent, highly reproducible, and nonselective, and it requires little or no sample preparation [60] . NMR data can provide large amounts of molecular information, including metabolite structure, concentration, and flux through pathways. Furthermore, NMR is noninvasive and nondestructive to samples, thereby permitting the re-use of the sample for other studies. For example, the recently developed HRMAS NMR method, derived from solid-state NMR technique, is carried out to achieve high-resolution NMR spectroscopy for intact tissues, which are comparable to that in the liquid state [61, 62] . In addition, signals from different metabolites can be selectively obtained by employing many NMR spectral editing techniques with pulse sequences designed according to molecular relaxation time and diffusion rate, which are very useful for spectral simplification and metabolite identification [63] .
However, the polarization rate in NMR obeys the Boltzmann distribution law, resulting in small population differences between the ground and excited state of the atomic nucleus. Conventional NMR, therefore, suffers from relatively low sensitivity-the technique's major disadvantage, which is most apparent when compared with mass spectrometry. There are two ways to improve NMR sensitivity. One is to reduce electronic noise levels using the cryogenic probe technique, in which the temperature of the electronic detection circuits is reduced to approximately 20 K, thereby increasing detection sensitivity by approximately fourfold. The second is to reduce chemical noise resulting from signal overlap using higher magnetic fields. Currently, the standard 600 MHz spectrometer, equipped with an optimized cryogenic probe, can detect metabolites approaching nanomolar concentrations.
An Overview of NMR-Based Metabolomic Application in Cancer Research
Normal cells transforming into cancer cells usually undergo changes in cellular metabolism. During these changes, the cells consume ATP for de novo synthesis of nucleotides, lipids, and proteins, thus ensuring rapid cell proliferation. Such molecular information of cellular metabolism plays an important role in our understanding of the development and progression of cancer. Cancer can be influenced by many factors, such as diet, environment, and lifestyle [64] . Among all of the "omics" approaches, only metabolomics technology has provided a suitable tool in investigations of pathwayspecific metabolic alterations in the development and progression of cancer and could possibly be employed in the clinical diagnosis of cancer [59] . To date, many metabolomic studies using different analytical platforms and biological matrices have been performed to identify the metabolic differences between normal cells and cancer cells [23] [24] [25] . In these studies, the NMR-based metabolomic approach provided a unique opportunity for detecting global molecular information as a readout of biochemical processes. Here, an overview of previous NMR-based metabolomic cancer studies is presented according to the sample matrices used.
NMR-Based Metabolomic Analysis of Plasma/Serum and Urine in Cancer
Blood plasma/serum NMR spectra contain signals from lipoproteins, glycoproteins, glucose, amino acids, carboxylic acids (e.g., lactate), ketone bodies, and choline metabolites. NMR-based metabolomic analysis of blood is used to generate a global overview of the whole organism metabolism. However, its composition can be influenced by different tissues, organs, and changes in the gut microbiota; therefore, changes detected in the blood may not accurately reflect the disease state. For instance, alterations in metabolites associated with glycolysis involved in energy metabolism were observed in various cancers and other diseases, such as diabetes [65] . Therefore, the interpretation of data obtained from metabolomics results should be carefully weighed not only against potentially confounding factors but also against the specificity of the biomarker identified. The well-known Warburg effect in cancer showed that glycolytic production of ATP, rather than oxidative phosphorylation via the tricarboxylic acid (TCA) cycle, is commonly observed in cancer cell metabolism [66] . The downregulation of plasma glucose, together with elevation in keto-bodies (3-hydroxybutyrate (3-HB) and pyruvate) and lactate, were also referred to as supporting evidence for cancer with a unique glucose metabolic phenotype [23] . Ng et al. summarized metabolic pathways and respective metabolites as biomarkers perturbed in different cancers, which indicated that some of the significantly changed metabolites can be observed in plasma or serum samples using NMR-based metabolomics [67] . In particular, those metabolites related to glucose, amino acid, and nucleic acid metabolism are commonly observed in high-resolution NMR spectra. Garcia et al. demonstrated that 1 H NMR-based metabolomics of serum allows for the accurate discrimination between healthy women and advanced stage III/IV and early stage I/II epithelial ovarian cancer (EOC) through the use of logistic regression on principal components of the NMR profiles and a statistical predictive model [26] . The observation that 3-HB concentrations were found to have increased in both stages of EOC suggests that 3-HB could be an early diagnostic biomarker [26] . In order to further perform targeted and cancer typespecific analysis for blood samples, isotopomer techniques combined with stable and labile metabolite extraction techniques are extensively used in NMR-based metabolomic cancer studies. For example, Fan et al. infused 13 C glucose, an excellent tracer molecule, into human lung cancer patients and analyzed tissues and blood plasma by 13 C isotopmer-based metabolomic studies using a combination of NMR and gas chromatography coupled with mass spectrometry (GC/MS) [68] . The results showed that lung tissue from lung cancer patients was identified by increased incorporation of carbon from glucose into a variety of metabolites, including TCA cycle intermediates as well as nucleotides [68] . The advantage of the stable isotope-labeled NMR metabolomic approach in cancer is the chemical library of 13 C-labeled isotopes [69] including 13 C-labeled amino acids (such as glutamine, serine, and glycine [70] ), 13 C-labeled acetate, and 31 P-labeled phosphorylcholine [71] -thus allowing the determination of metabolic pathways in cancer related to protein and fatty acid synthesis, nucleic acid synthesis, nucleotide synthesis, TCA cycle, and carbohydrate metabolism. It should be noted that this approach is equally applicable to MS-based approaches.
Urine is commonly used to study bladder and kidney cancers [72, 73] as well as a host of other nonrenal-related studies, including hepatocellular carcinoma [74] , breast cancer [75] , lung cancer [76] , and colorectal cancer [77] . Approximately 40 urinary endogenous metabolites can be identified from 600 MHz 1 H NMR spectra, which include amino acids, such as glycine, leucine, iosleucine, valine, alanine, and tyrosine. Also included are ketone bodies (3-HB and acetoacetate), hippurate, phenylacetylglycine (PAG), indoleacetylglycine (IAG), urea, and various organic acids, including 2-oxoglutarate, citrate, taurine, succinate, fumarate, lactate, formate, β-hydroxyisovalerate, α-hydroxyisobutyrate, and creatine. However, urine composition tends to vary with diet, and xenobiotics and their metabolites can substantially increase variability in the metabolomic profile. Usually, the concentration of those xenobiotic metabolites is too low to be detected by NMR, thereby permitting one to focus mostly on the endogenous metabolites. Among these urinary metabolites, glycine involved in methionine metabolism was observed as a biomarker in kidney cancer by 1 H NMR. The alterations of urinary 2-oxoglutarate, citrate, succinate, and fumarate are usually regarded as indicators of TCA cycle disruptions in almost all cases. The urinary aromatic metabolites, hippurate, PAG, and IAG are mainly produced by acyl-CoA catalysis in the liver as the conjugation of benzoic acid, phenylacetic acid, and indoleacetic acid [78] . It is noteworthy that they are also co-metabolites of host and bacteria. Therefore, the alterations of these urinary aromatic metabolites were reflective of liver dysfunction in liver cancer, and variations in their concentration may be related to modulation of activity or population of gut microbiota [79] , which warrants further investigation to address the challenges of the microbiome in metabolomic research. In addition, Carrola et al. have examined the urinary metabolic profiles of lung cancer patients and controls using an NMR-based metabolomic approach [76] . The results showed that lower levels of hippurate and trigonelline, as well as higher levels of β-hydroxyisovalerate, α-hydroxyisobutyrate, Nacetylglutamine, and creatinine, were observed in lung cancer patients than in controls. These putative biomarkers in urine of lung cancer were supportive evidence and were found to be specifically disease-related [76] .
NMR-Based Metabolomic Analysis of Intact Tissue and Tissue Extraction in Cancer
More recently, HRMAS NMR methods have been developed to enable studies for intact tissues, which have potential to provide molecular information associated with pathology [80] . This is achieved by spinning the tissue samples at the "magic angle" (54.7°) with respect to a magnetic field so as to produce high-resolution NMR spectra from soft tissues by averaging out a range of NMR line broadening factors, such as dipole-dipole interactions, chemical shift anisotropy, and magnetic field inhomogeneity. For example, the metabolic features of human HCC in low-grade human HCC, highgrade HCC tumors, and the adjacent normal liver tissues were recently characterized employing HRMAS NMR spectroscopy in conjunction with pattern recognition techniques. This approach was useful in categorizing HCC according to histological type and grade [28] . Organ-specific biomarkers involved in metabolic pathways have also been investigated using HRMAS 1 H NMR-based metabolomic technique. For example, some metabolic pathways, including urea cycle (tyrosine, fumarate, arginine, and aspartate), pyrimidine metabolism (glutamine), and pyruvate metabolism (lactate and malate) were found to be related to colorectal cancer [67] . Ethanolamine and choline associated with phospholipid biosynthesis were examined as biomarkers in prostate and breast cancer tissues [67] . Griffin et al. investigated brain tumor metabolism using 1 H NMR-based metabolomics [81] . Furthermore, Tsang and coworkers used metabolic profiling to characterize different brain regions in rats ex vivo by HRMAS 1 H NMR [82] . Unique metabolite signatures were identified in the brain stem, frontal cortex, cerebellum, and hippocampus. In particular, a novel method-the combination of NMR-based metabolomics and imaging (e.g., MRI) techniques-was exploited by Cheng et al. to identify possible connections between metabolism and specific pathological conditions [83] . Using this method, Wu and coworkers evaluated prostates removed during prostatectomy from cancer patients (identified and confirmed by histology) on a 7 T human whole-body magnetic resonance scanner [84] , and a malignancy index based on prostate cancer metabolic profiles was constructed. Furthermore, the calculation of malignancy index about the corrections between NMR metabolomic data and lesion size in cancer demonstrated a 93 to 97 % overall accuracy for prostate cancer detection [84] . Such application of an NMR-based in vivo/in vitro metabolomic method suggested the great potential clinical utility of this approach.
It is conceivable that the resolution of NMR spectra obtained from tissue extraction is higher than that obtained from intact tissue. Specifically, nucleic acid signals and nucleotide metabolites are easily observed in NMR spectra of tissue extracts, whereas only a few, such as inosine and adenosine, can be detected in intact tissue due to their low concentration [85] . Therefore, purine and pyrimidine metabolism is best investigated with tissue extraction. For example, uracil and hypoxanthine were increased in colorectal, cervical, and ovarian cancers [86, 87] , due to their need for increased DNA synthesis and cell proliferation [86, 88] . However, the procedure and methods for tissue extraction are key factors governing the metabolomic results. Although many efforts aim to optimize the method of tissue extraction, two main shortcomings always occur: (1) the choice of solvents and extraction procedure as not all metabolites can be extracted in one method and (2) the loss of metabolites during the extraction procedure, regardless of which solvents and methods are used. The abovementioned HRMAS 1 H NMR method allows one to carry out experiments with intact tissues, which are much closer to the physiological status of an animal. Therefore, both intact tissues and extracts of tissues are used to perform NMRbased metabolomic research in order to ensure rigorous and reproducible results.
An Overview of NMR-Based Metabolomic Application in Drug Metabolism
Metabolite profiling and drug metabolite mapping have been informative for understanding hepatotoxicity, development toxicity, and nephrotoxicity [60, 85] . Apart from druginduced toxicity, understanding drug metabolism itself is also very important in assessing the safety and efficacy of a new drug, since drug metabolites themselves can significantly affect a drug's safety profile. Identification of biomarkers found in biofluid samples, such as blood and urine, after drug administration is expected to help elucidate the mechanism of drug action. Furthermore, drug metabolite mapping may provide important data to understand the pathophysiological effects associated with drug efficacy, selectivity, and toxicity. Therefore, in vivo animal and human studies are essential to best understand the molecular mechanism of drug action and to understand how endogenous metabolism is affected by drug metabolism.
NMR-based metabolomics is a powerful tool for systematically and rapidly identifying drug and endogenous metabolites from global profiling combined with multivariate statistical data analysis [89] . For example, NMR-based metabolic profiling was utilized to evaluate the pharmacokinetics of acetaminophen (APAP) treatment by profiling in urine its major metabolites [90] . Results indicated that the urinary level of the major APAP metabolite, N-acetyl-L-cysteine acetaminophen (APAP-NAC, a metabolite formed from the reactive intermediate N-acetyl-p-benzoquinone imine), was detected by NMR and found to be significantly associated with clinical chemistry data (increased ALT/AST) and endogenous oxidative stress-related metabolites such as reduced glutathione and oxidized glutathione [90] . Thus, the toxicity of APAP can be monitored indirectly through the urinary excretion of APAP-NAC and other metabolites. Interestingly, NMR-based metabolic profiling of pre-dose and post-dose urinary metabolites showed that humans with high predose levels of p-cresol (a metabolite often associated with gut microbiota metabolism) had lower concentrations of APAP sulfate. This observation might suggest that individuals with lower urinary concentrations of APAP sulfate might be more susceptible to APAP-induced hepatotoxicity, since less APAP was detoxified through urine by sulfate conjugation [91] . Furthermore, these observations suggest that the composition of the gut microbiota should be considered when evaluating new drugs and when studying idiosyncratic drug reactions. Previous study of the drug rosiglitazone in type 2 diabetes mellitus (T2DM) patients revealed that NMR-based metabolomic analysis could provide indications of responders, and this information should be beneficial to the clinical development of new drugs (e.g., thiazolidinediones) for T2DM [92] . Recently, Steven et al. employed NMR-based metabolomic approaches to profile the mechanisms of action of known antibiotics, such as streptomycin and ciprofloxacin, used to treat Mycobacterium tuberculosis. Results demonstrated that different classes of antibiotics uniquely modulated the metabolome of Mycobacterium smegmatis, a nonpathogenic model organism for M. tuberculosis [93, 94] . NMR-based plant metabolomics has also been employed to provide support for phytomedicine development and research, which are used extensively worldwide; study of their mechanism of action may help to identify new lead compounds [95] . Focusing on the bioactive components of herbal medicines and extracts may help to bolster claims regarding their efficacy. Taken together, these findings indicated that NMR-based metabolomics provides an efficient and unbiased approach for rapid classification, metabolism, and evaluation of lead drug candidates as well as in personalized health care.
Conclusion
It is anticipated that NMR-based metabolomics will continue to be an important global systems biology tool and will be applied to many aspects of biomedical research, including clinical diagnosis and prognosis for cancer and other diseases. Undeniably, the combination of multiple platforms, such as NMR-based and MS-based metabolomics, and the integration and interpretation of data from various omics-including genomics, transcriptomics, and proteomics-will enable us to obtain comprehensive insight into important metabolic processes contributing to health and disease.
